| Brand Name | FARAWAVE? |
| Common Device Name | Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation |
| Manufacturer (Section D) |
| BOSTON SCIENTIFIC CORPORATION |
| 300 boston scientific way |
| marlborough MA 01752 |
|
| Manufacturer (Section G) |
| Boston Scientific Corporation |
| 302 parkway, global park |
|
| la aurora - heredia |
|
CS
|
|
| Manufacturer Contact |
|
mary
crawford
|
| 4100 hamline avenue north |
| dc a330 |
| saint paul, MN 55112
|
|
+1(651)440-0979
|
|
| MDR Report Key | 50601438 |
| Report Number | 2124215-2026-47020 |
| Device Sequence Number | 10600230 |
| Product Code |
QZI
|
| UDI-Device Identifier | 00191506043148 |
| Combination Product (Y/N) | N |
| Initial Reporter Country | JA |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Reporter Type |
Manufacturer
|
| Report Source |
Other,Foreign,Health Professional,Company Representative |
| Initial Reporter Occupation |
Physician
|
| Type of Report
| Initial,Followup |
| Report Date (Section B) |
09/30/2026 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
No
|
| Operator of Device |
Health Professional
|
| Device Lot Number | 0035929060 |
| Was Device Available for Evaluation? |
No
|
| Is the Reporter a Health Professional? |
Yes
|
| Type of Report(Section G) | Thirty-Day |
| Initial Date Received by Manufacturer | Not provided |
| Supplement Date Received by Manufacturer | 09/28/2026
|
| Initial Report FDA Received Date | 09/04/2026 |
| Supplement Report FDA Received Date | 09/30/2026
|
| Date Device Manufactured | 02/24/2025 |
| Is the Device Labeled for Single Use? (Y/N) |
Yes
|
| Usage of Device |
Initial
|
| Patient Sequence Number | 1 |
| Outcome Attributed to Adverse Event |
Other;
|
| Patient Age | 60 YR |
| Patient Sex | Male |
| Patient Weight | 149 LB |
|
|